Passive Transdermal Drug Delivery Market Report

Global and China Passive Transdermal Drug Delivery Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 22, 2022
  • PAGES：175
  • REPORT CODE：GMM1483479
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Passive Transdermal Drug Delivery industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • 3M

    • Actavis, Inc

    • Boehringer Ingelheim GmbH

    • Novartis AG

    • Echo Therapeutics, Inc

    • Johnson & Johnson (Janssen Pharmaceuticals Inc)

    • Corium International, Inc

    • Bayer AG

    • Transdermal Corp

    • Noven Pharmaceuticals, Inc

    • GlaxoSmithKline plc

    • Mylan NV

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Microfluidics

    • Smart Pill Technology (SPT)

    Application:

    • Clinic

    • Hospital

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Passive Transdermal Drug Delivery Industry Overview

      • 1.1.1 Passive Transdermal Drug Delivery Market Scope and Market Segments

      • 1.1.2 Passive Transdermal Drug Delivery Industry Characteristics

      • 1.1.3 Global and China Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Passive Transdermal Drug Delivery Production Value and Growth Rate (2017-2028)

    • 1.2 Global Passive Transdermal Drug Delivery Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Microfluidics

      • 1.2.2 Smart Pill Technology (SPT)

    • 1.3 Global Passive Transdermal Drug Delivery Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Clinic

      • 1.3.2 Hospital

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Passive Transdermal Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Passive Transdermal Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Passive Transdermal Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Passive Transdermal Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Passive Transdermal Drug Delivery Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Passive Transdermal Drug Delivery Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Passive Transdermal Drug Delivery Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Passive Transdermal Drug Delivery Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Passive Transdermal Drug Delivery Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Passive Transdermal Drug Delivery Industry Porter's Five Forces Model Analysis

      • 2.2.3 Passive Transdermal Drug Delivery Industry PEST Analysis

    • 2.3 Passive Transdermal Drug Delivery Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Passive Transdermal Drug Delivery Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Passive Transdermal Drug Delivery Industry

    Chapter 3 Global and China Passive Transdermal Drug Delivery Market, by Manufacturer

    • 3.1 Global and China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Passive Transdermal Drug Delivery Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Passive Transdermal Drug Delivery Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Passive Transdermal Drug Delivery Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Passive Transdermal Drug Delivery Market Top 3 Players

    Chapter 4 Global and China Passive Transdermal Drug Delivery Market, by Type (2017-2028)

    • 4.1 Passive Transdermal Drug Delivery Market Trend, by Type

    • 4.2 Global Passive Transdermal Drug Delivery Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Passive Transdermal Drug Delivery Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Passive Transdermal Drug Delivery Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Passive Transdermal Drug Delivery Price Trend, by Type (2017-2028)

    • 4.3 China Passive Transdermal Drug Delivery Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Passive Transdermal Drug Delivery Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Passive Transdermal Drug Delivery Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Passive Transdermal Drug Delivery Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Passive Transdermal Drug Delivery Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Passive Transdermal Drug Delivery Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Passive Transdermal Drug Delivery Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Passive Transdermal Drug Delivery Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Passive Transdermal Drug Delivery Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Passive Transdermal Drug Delivery Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Passive Transdermal Drug Delivery Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Passive Transdermal Drug Delivery Market Analysis

    • 7.1 North America Passive Transdermal Drug Delivery Market, by Type

    • 7.2 North America Passive Transdermal Drug Delivery Market, by Application

    • 7.3 North America Passive Transdermal Drug Delivery Market Analysis and Forecast, by Country

      • 7.3.1 United States Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Passive Transdermal Drug Delivery Market Analysis

    • 8.1 Europe Passive Transdermal Drug Delivery Market, by Type

    • 8.2 Europe Passive Transdermal Drug Delivery Market, by Application

    • 8.3 Europe Passive Transdermal Drug Delivery Market Analysis and Forecast, by Country

      • 8.3.1 Germany Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Passive Transdermal Drug Delivery Market Analysis

    • 9.1 APAC Passive Transdermal Drug Delivery Market, by Type

    • 9.2 APAC Passive Transdermal Drug Delivery Market, by Application

    • 9.3 APAC Passive Transdermal Drug Delivery Market Analysis and Forecast, by Country

      • 9.3.1 China Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Passive Transdermal Drug Delivery Market Analysis

    • 10.1 Latin America, Middle East and Africa Passive Transdermal Drug Delivery Market, by Type

    • 10.2 Latin America, Middle East and Africa Passive Transdermal Drug Delivery Market, by Application

    • 10.3 Latin America, Middle East and Africa Passive Transdermal Drug Delivery Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Passive Transdermal Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Passive Transdermal Drug Delivery Company Profiles

      • 11.1 3M

        • 11.1.1 3M Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 3M Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.1.3 3M Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Actavis, Inc

        • 11.2.1 Actavis, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Actavis, Inc Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.2.3 Actavis, Inc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Boehringer Ingelheim GmbH

        • 11.3.1 Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.3.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Novartis AG

        • 11.4.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Novartis AG Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.4.3 Novartis AG Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Echo Therapeutics, Inc

        • 11.5.1 Echo Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Echo Therapeutics, Inc Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.5.3 Echo Therapeutics, Inc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Johnson & Johnson (Janssen Pharmaceuticals Inc)

        • 11.6.1 Johnson & Johnson (Janssen Pharmaceuticals Inc) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.6.3 Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Corium International, Inc

        • 11.7.1 Corium International, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Corium International, Inc Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.7.3 Corium International, Inc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Bayer AG

        • 11.8.1 Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Bayer AG Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.8.3 Bayer AG Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Transdermal Corp

        • 11.9.1 Transdermal Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Transdermal Corp Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.9.3 Transdermal Corp Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Noven Pharmaceuticals, Inc

        • 11.10.1 Noven Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.10.3 Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 GlaxoSmithKline plc

        • 11.11.1 GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.11.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Mylan NV

        • 11.12.1 Mylan NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Mylan NV Passive Transdermal Drug Delivery Product Profiles, Application and Specification

        • 11.12.3 Mylan NV Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Passive Transdermal Drug Delivery Industry Investment Prospect and Risk Assessment

    • 12.1 Passive Transdermal Drug Delivery Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Passive Transdermal Drug Delivery Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Production Value and Growth Rate (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Production Value and Growth Rate (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Market Size and Growth Rate of Microfluidics (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Market Size and Growth Rate of Smart Pill Technology (SPT) (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Passive Transdermal Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Passive Transdermal Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Passive Transdermal Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Passive Transdermal Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Passive Transdermal Drug Delivery Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Passive Transdermal Drug Delivery Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Passive Transdermal Drug Delivery Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Passive Transdermal Drug Delivery Market Share, by Manufacturer in 2021

    • Figure Global and China Passive Transdermal Drug Delivery Market Share, by Manufacturer in 2022

    • Table Global Passive Transdermal Drug Delivery Sales Volume, by Type (2017-2028)

    • Table Global Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table Global Passive Transdermal Drug Delivery Sales Value, by Type (2017-2028)

    • Table Global Passive Transdermal Drug Delivery Sales Value Share, by Type (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Price Trend, by Type (2017-2028)

    • Table China Passive Transdermal Drug Delivery Sales Volume, by Type (2017-2028)

    • Table China Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table China Passive Transdermal Drug Delivery Sales Value, by Type (2017-2028)

    • Table China Passive Transdermal Drug Delivery Sales Value Share, by Type (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Price Trend, by Type (2017-2028)

    • Table Global Passive Transdermal Drug Delivery Sales Volume, by Application (2017-2028)

    • Table Global Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Table Global Passive Transdermal Drug Delivery Sales Value, by Application (2017-2028)

    • Table Global Passive Transdermal Drug Delivery Sales Value Share, by Application (2017-2028)

    • Figure Global Passive Transdermal Drug Delivery Sales Value Share, by Application (2017-2028)

    • Table China Passive Transdermal Drug Delivery Sales Volume, by Application (2017-2028)

    • Table China Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Table China Passive Transdermal Drug Delivery Sales Value, by Application (2017-2028)

    • Table China Passive Transdermal Drug Delivery Sales Value Share, by Application (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Sales Value Share, by Application (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Figure North America Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Passive Transdermal Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Table North America Passive Transdermal Drug Delivery Sales Volume, by Type (2017-2028)

    • Table North America Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure North America Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table North America Passive Transdermal Drug Delivery Sales Volume, by Application (2017-2028)

    • Table North America Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure North America Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure United States Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure United States Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Canada Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Table Europe Passive Transdermal Drug Delivery Sales Volume, by Type (2017-2028)

    • Table Europe Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure Europe Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table Europe Passive Transdermal Drug Delivery Sales Volume, by Application (2017-2028)

    • Table Europe Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure Europe Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure Germany Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure UK Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure UK Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure France Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure France Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Italy Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Spain Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Poland Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Russia Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Table APAC Passive Transdermal Drug Delivery Sales Volume, by Type (2017-2028)

    • Table APAC Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure APAC Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table APAC Passive Transdermal Drug Delivery Sales Volume, by Application (2017-2028)

    • Table APAC Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure APAC Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure China Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Japan Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure India Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure India Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Passive Transdermal Drug Delivery Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Passive Transdermal Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Passive Transdermal Drug Delivery Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Passive Transdermal Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Passive Transdermal Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Passive Transdermal Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Table 3M Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table 3M Product Profiles, Application and Specification

    • Table 3M Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Actavis, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Actavis, Inc Product Profiles, Application and Specification

    • Table Actavis, Inc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim GmbH Product Profiles, Application and Specification

    • Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Echo Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Echo Therapeutics, Inc Product Profiles, Application and Specification

    • Table Echo Therapeutics, Inc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Product Profiles, Application and Specification

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Corium International, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Corium International, Inc Product Profiles, Application and Specification

    • Table Corium International, Inc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG Product Profiles, Application and Specification

    • Table Bayer AG Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Transdermal Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Transdermal Corp Product Profiles, Application and Specification

    • Table Transdermal Corp Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Noven Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Noven Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Noven Pharmaceuticals, Inc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mylan NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mylan NV Product Profiles, Application and Specification

    • Table Mylan NV Passive Transdermal Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US